Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery.
Ke XuNoel C ChanJack HirshJeffrey S GinsbergVinai BhagirathPaul KrugerBrian DaleMark CrowtherRichard P WhitlockChunjian LiJohn W EikelboomPublished in: European journal of haematology (2018)
Of the 3 markers, IPC was the most promising as surrogates for platelet production. Future studies should evaluate the utility of the IPC to identify patients with cardiovascular disease with reduced response to aspirin who might benefit from twice-daily aspirin.
Keyphrases
- coronary artery bypass grafting
- cardiovascular disease
- percutaneous coronary intervention
- low dose
- cardiovascular events
- antiplatelet therapy
- coronary artery disease
- coronary artery bypass
- minimally invasive
- type diabetes
- physical activity
- acute coronary syndrome
- current status
- anti inflammatory drugs
- cardiovascular risk factors
- surgical site infection
- atrial fibrillation